Suzanne O'Connor

Suzanne is a Senior Drug Discovery Scientist and team leader at the Centre for Targeted Protein Degradation, University of Dundee working with Cancer Grand Challenges’ KOODAC team developing degrader drugs for paediatric oncology.  Prior to joining KOODAC, she led multi-disciplinary teams for PROTAC drug discovery projects for the treatment of cancer, in a collaboration between Professor Alessio Ciulli and Boehringer Ingelheim. She has a Medicinal Chemistry degree from Trinity College Dublin, a Research Masters in Drug Discovery and Development from Imperial College London and a PhD in Fragment Based Drug Discovery from the Institute of Cancer Research. Prior to joining the Centre for Targeted Protein Degradation, Suzanne worked at Evotec in lead optimisation drug discovery for the treatment of chronic pain, and at AstraZeneca on a variety of oncology drug discovery projects.